University of Groningen Quantification of the Potential Impact of Cost - effectiveness Thresholds on Dutch Drug Expenditures Using
نویسندگان
چکیده
Background: Other than the UK, The Netherlands has no formal threshold for cost-per-QALY values defined yet. For example, a cutoff value at €20,000 per QALY is sometimes mentioned in various discussions, however it has no formal status at all. Yet, since 2005, all new innovative do have to go through a cost-effectiveness evaluation though, with the assessment being focused on the methodology rather than on the exact cost-per-QALY outcome. Objective: Our objective was to estimate the potential impacts on Dutch drug expenditures had a formal threshold been applied in recent years. Methods: We analyzed national Dutch prescription data for the period 2005–2007, with respect to the costs of specific newly introduced drugs with reported positive cost-effectiveness ratios. Various threshold values
منابع مشابه
Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysis.
BACKGROUND Other than the UK, The Netherlands has no formal threshold for cost-per-QALY values defined yet. For example, a cutoff value at €20,000 per QALY is sometimes mentioned in various discussions, however it has no formal status at all. Yet, since 2005, all new innovative do have to go through a cost-effectiveness evaluation though, with the assessment being focused on the methodology rat...
متن کاملCost-effectiveness of Methadone Maintenance Treatment Centers in Prevention of Human Immunodeficiency Virus Infection
Background: Acquired immune deficiency syndrome (AIDS) is one of the greatest social health problems in many communities in the twenty-first century. Methadone maintenance treatment (MMT) could decrease HIV infection among injection drug users (IDU). The main aim of this paper was to determine the cost-effectiveness of the governmental MMT program to prevent human immunodeficiency virus (HIV) i...
متن کاملFactors Influencing Pharmaceutical Demand in Iran: Results from a Regression Study
Background and Objectives: Pharmaceutical expenditures are responsible for a major part of health systems’ cost. According to the WHO’s statistics, Iran is the first among the 20 countries in the world in terms of drug consumption. The first step in controlling consumption of a particular good is to identify factor inducing the relevant demands. Hence, this study aimed to identify the pattern a...
متن کاملThe impact of children’s entry to labor market on health expenditures of urban household
Child labor is regarded as an ambiguous and controversial challenge encountered in majority of countries across the world. Given the incidence and prevalence of this phenomenon in Iran and the importance of household health expenditures, this study was done to evaluate the impact of children’s entry into labor market on household health expenditures. This study was conducted on urban households...
متن کاملApplying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran
HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a suitable model for Iranian population to determine the potential cost effectiveness of HPV vaccine p...
متن کامل